Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Amarin Corporation plc

Amarin Corporation is a specialty pharmaceutical company focused on pain management and neurology.

Amarin is following three specific strategies:

Deriving sales growth from its existing product lines.



Opportunistic acquisition of branded growth products from other pharmaceutical companies.



Continued in-licensing of late stage development products (Phase II or Phase III) via an active "search and development" program.


Contact Details:
7 Curzon Street
London
W1J 5HG
United Kingdom
Tel:0207 499 9009
Fax:+44 (0) 20 7499 9004
Email:rick.stewart@amarincorp.com
WWW:

www.amarincorp.com/




Loading...

Press Releases on Amarin Corporation plc:

BioPortfolio Logo
Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions 25th August, 2009 Adamas Pharmaceuticals, Inc.
-- ADS-8703, a proprietary fixed-dose combination for the symptomatic treatment of dementia. About Mr. Coffee and Dr. Patick Mr. Coffee brings more than 30 years sales, marketing and
Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 22nd July, 2008 Amarin Corporation Plc
DUBLIN, Ireland, July 22 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRN) today announced that the Company recently met with officials at the U.S. Food and Drug Administration (FDA)
Amarin - Notice of Annual General Meeting 8th July, 2008 Amarin Corporation Plc
DUBLIN, July 8 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRN) announced today it has sent to its shareholders a Notice of the Annual General Meeting of the Company, which will be

BioNews Results for Amarin Corporation plc:

Irish biotech moves operations base to CT (posted Yesterday at 11:10am)
Hartford Business Journal:  Nov 13 2009 12:52PM Matching: amarin plc
Irish biotech moves operations base to CT
Hartford Business Journal:  Nov 13 2009 8:17AM Matching: amarin plc
Amarin Appoints John F. Thero as Chief Financial Officer
Pharma Live:  Nov 6 2009 9:54PM Matching: amarin plc
Amarin Appoints John F. Thero as Chief Financial Officer
Genetic Engineering News:  Nov 6 2009 9:53AM Matching: amarin plc
Amarin Appoints Medpace as CRO for Two Phase 3 Cardiovascular Trials
Pharma Live:  Oct 22 2009 9:44AM Matching: amarin plc
Promote your company here: BioNewsCast - Press Release Distribution

View more Amarin Corporation plc news.

Amarin Corporation plc (AMRN) Financial information Links from Barchart

AMRN Quote from from Barchart.com
AMRN Chart from from Barchart.com
AMRN Profile from from Barchart.com
AMRN Opinion from from Barchart.com

View more Amarin Corporation plc finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1155 times since April 2007, the link to the organisation's website has been followed 195 times

Recent Search Terms used to find this page: ADS-8703 phase ii details dementia | amarin corporation | Amarin Corporation email contact information | amarin corporation shareholders 2009 | Amarin Corporation plc | Amarin Corp | Amarin Corporation | Amarin Corporation Plc london | amarin corporation contact | Amarin Corp | .

Search for more companies in London

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Amarin Corporation plc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.